Standard Biotools (LAB) Net Cash Flow Growth (3y) (2013 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.43 Bn | 221.37 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 144.26 Bn | 139.91 Bn | 3.61 Bn | -44.88% |
| 3 | Agilent Technologies | 40.88 Bn | 39.12 Bn | 1.04 Bn | -31.58% |
| 4 | Illumina | 30.92 Bn | 29.75 Bn | 770.00 Mn | -40.43% |
| 5 | Revvity | 13.86 Bn | 12.84 Bn | 416.87 Mn | 29.57% |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | 0.45% |
| 7 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn | 27.19% |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn | -35.32% |
| 9 | 10x Genomics | 8.74 Bn | 8.18 Bn | 112.50 Mn | 50.05% |
| 10 | Standard Biotools | 283.04 Mn | -193.68 Mn | 10.54 Mn | -48.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.34% |
| Mar 31, 2026 | 65.08% |
| Dec 31, 2025 | -34.15% |
| Sep 30, 2025 | -27.83% |
| Jun 30, 2025 | -46.25% |
| Mar 31, 2025 | -127.10% |
| Sep 30, 2024 | -14.44% |
| Jun 30, 2024 | 23.16% |
| Mar 31, 2024 | 143.92% |
| Dec 31, 2023 | -89.78% |
| Sep 30, 2023 | -60.74% |
| Jun 30, 2023 | 54.10% |
| Mar 31, 2023 | 36.37% |
| Dec 31, 2022 | 89.93% |
| Sep 30, 2022 | -112.73% |
| Jun 30, 2022 | 46.31% |
| Mar 31, 2022 | 27.12% |
| Sep 30, 2021 | -125.86% |
| Jun 30, 2021 | -157.38% |
| Mar 31, 2021 | -4.54% |